PERMANENT IN-HOME BENEFIT FOR IVIG SERVICES.

SEC. 4134. PERMANENT IN-HOME BENEFIT FOR IVIG SERVICES.(a) Coverage.—Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended—(1) in subsection (s)(2)(Z) by inserting “, and items and services furnished on or after January 1, 2024, related to the administration of intravenous immune globulin,” after “globulin”; and (2) in subsection (zz), by inserting “furnished before January 1, 2024,” after “but not including items or services”. (b) Payment.—Section 1842(o) of the Social Security Act (42 U.S.C. 1395u(o)) is amended by adding at the end the following new paragraph:“(8) In the case of intravenous immune globulin described in section 1861(s)(2)(Z) that are furnished on or after January 1, 2024, to an individual by a supplier in the patient’s home, the Secretary shall provide for a separate bundled payment to the supplier for all items and services related to the administration of such intravenous immune globulin to such individual in the patient’s home during a calendar day in an amount that the Secretary determines to be appropriate, which may be based on the payment established pursuant to subsection (d) of section 101 of the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012. For purposes of the preceding sentence, such separate bundled payment 136 STAT. 5921 shall not apply in the case of an individual receiving home health services under section 1895.” . (c) Clarification With Respect to Payment for the In-home Administration of IVIG Items and Services.—Section 1834(j)(5) of the Social Security Act (42 U.S.C. 1395m(j)(5)) is amended—(1) by redesignating subparagraphs (E) and (F) as subparagraphs (F) and (G), respectively; and (2) by inserting after subparagraph (D) the following new subparagraph:“(E) items and services related to the administration of intravenous immune globulin furnished on or after January 1, 2024, as described in section 1861(zz);” . (d) Coinsurance.—Section 1833(a)(1) of the Social Security Act (42 U.S.C. 1395l(a)(1), as amended by section 4121(a) and section 4133(a), is amended—(1) by striking “and” before “(GG)”; and (2) by inserting before the semicolon at the end the following: “, and (HH) with respect to items and services related to the administration of intravenous immune globulin furnished on or after January 1, 2024, as described in section 1861(zz), the amounts paid shall be the lesser of the 80 percent of the actual charge or the payment amount established under section 1842(o)(8)”. (e) Additional Funding for Medicare IVIG Demonstration Project.—(1) Funding.—There is authorized to be appropriated, and there is hereby appropriated, out of any monies in the Treasury not otherwise appropriated, $4,300,000 for purposes of paying for items and services furnished under the demonstration project established by the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 (42 U.S.C. 1395l note). (2) Supplement, not supplant.—Any amounts appropriated pursuant to this subsection shall be in addition to any other amounts otherwise appropriated pursuant to any other provision of law.